BRIEF RESEARCH REPORT
Published on 05 Dec 2024
Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma
doi 10.3389/fimmu.2024.1495004
- 322 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Immunotherapy of Skin Cancer
Immunology and Immunotherapy of Skin Cancer
3,253
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 04 Dec 2024
The role of circulating tumor DNA in melanomas of the uveal tract
doi 10.3389/fimmu.2024.1509968
- 341 views
ORIGINAL RESEARCH
Published on 02 Dec 2024
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
doi 10.3389/fimmu.2024.1490821
ORIGINAL RESEARCH
Published on 04 Sep 2024
A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT)
doi 10.3389/fonc.2024.1385685
- 843 views
REVIEW
Published on 16 Jul 2024
Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review
doi 10.3389/fonc.2024.1400193
- 1,610 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jul 2024
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab)
doi 10.3389/fimmu.2024.1408667
- 1,761 views
ORIGINAL RESEARCH
Published on 10 Jun 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
doi 10.3389/fimmu.2024.1395225
- 1,123 views
ORIGINAL RESEARCH
Published on 05 Jun 2024
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
doi 10.3389/fimmu.2024.1383125
- 1,037 views
- 1 citation
MINI REVIEW
Published on 18 Mar 2024
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma—two sides of the same coin?
doi 10.3389/fimmu.2024.1385781
- 1,967 views
- 3 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Vaccines and Molecular Therapeutics
- Antigen Presenting Cell Biology
- T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Frontiers in Public Health
Vaccines and Molecular TherapeuticsOffline
- 3.0 impact factor
- 4.8 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 12kTopic views
- 8,275Article views
- 3,253Article downloads